The small patient numbers to date mean that further evaluation will be required to establish whether there is any association between genetic and environmental factors that contribute to the clinical outcome of serum AFP levels in different subsets of Asian patients with hepatoblastoma. This evidence concerns the gene AFP and hepatoblastoma.